Neurogastrx

OverviewSuggest Edit

Neurogastrx is a biopharmaceutical company developing products for the treatment gastrointestinal disorders treatment. Its lead product is under development for the treatment of gastroparesis, a debilitating condition caused by abnormal gastric function.

TypePrivate
Founded2012
HQWoburn, MA, US
Websiteneurogastrx.com

Latest Updates

Employees (est.) (Oct 2021)11(+10%)
Cybersecurity ratingAMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at Neurogastrx

Klaus Veitinger

Klaus Veitinger

Chairman of the Board
Jim O'Mara

Jim O'Mara

President and Chief Executive Officer, Director
David Allison

David Allison

Director
Sara Burke

Sara Burke

Head of Program Management
Kevin Koch

Kevin Koch

Director
Brenda Jeglinski

Brenda Jeglinski

Head of Clinical Operations
Show more

Neurogastrx Office Locations

Neurogastrx has an office in Woburn
Woburn, MA, US (HQ)
60 Unicorn Park Dr
Show all (1)

Neurogastrx Financials and Metrics

Summary Metrics

Founding Date

2012

Neurogastrx total Funding

$45 m

Neurogastrx latest funding size

$45 m

Time since last funding

4 years ago

Neurogastrx investors

Neurogastrx's latest funding round in January 2018 was reported to be $45 m. In total, Neurogastrx has raised $45 m
Show all financial metrics

Neurogastrx Cybersecurity Score

Cybersecurity ratingPremium dataset

A

95/100

SecurityScorecard logo

Neurogastrx Online and Social Media Presence

Embed Graph

Neurogastrx Blogs

Neurogastrx Secures $60 Million in Series B Financing and Expands Management Team to Advance Its Pipeline of Transformative Investigational Therapies for Gastrointestinal Disorders

Woburn, MA – August 26, 2021 – Neurogastrx, Inc., a privately held specialty pharmaceutical company developing transformative therapies for gastrointestinal (GI) disorders, announced today the successful completion of a $60 million Series B crossover round led by Vivo Capital. Other new investors pa…

Neurogastrx Frequently Asked Questions

  • When was Neurogastrx founded?

    Neurogastrx was founded in 2012.

  • Who are Neurogastrx key executives?

    Neurogastrx's key executives are Klaus Veitinger, Jim O'Mara and David Allison.

  • How many employees does Neurogastrx have?

    Neurogastrx has 11 employees.

  • Who are Neurogastrx competitors?

    Competitors of Neurogastrx include Alexion Pharmaceuticals, KiOmed Pharma and CorMedix.

  • Where is Neurogastrx headquarters?

    Neurogastrx headquarters is located at 60 Unicorn Park Dr, Woburn.

  • Where are Neurogastrx offices?

    Neurogastrx has an office in Woburn.

  • How many offices does Neurogastrx have?

    Neurogastrx has 1 office.